Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma : A Cost-Effectiveness Analysis.
Amar H KelkarEdward Robert Scheffer CliffCaron A JacobsonGregory A AbelStijntje Willemijn DijkEline M KrijkampRobert A ReddJoanna C ZurkoMehdi HamadaniM G Myriam HuninkCorey S CutlerPublished in: Annals of internal medicine (2023)
No research-specific funding.